The factsheet discloses Aequus as an unhedged holding at 3.89% of NAV.
Read this note →Research notes
What India's research desks published, reported with attribution and linked to the original notes. Orivam issues no recommendations of its own.
All houses
HDFC Securities
Motilal Oswal
Tata Asset Management
Mirae Asset Sharekhan
India IPO
Jainam
GEPL Capital
Way2Wealth
SBICAP Securities
Angel One
Axis Securities
ICICI Direct Research Retail
Religare
Arete Securities
Formerly known as Way2Wealth
ICICI Direct
Way2Wealth Securities
ICICI Securities
quant Mutual Fund
Kotak Securities
JM Financial
ICICI Securities – Retail
Global Markets by Vested
Ventura Securities
Prabhudas Lilladher
Industrial Asphalts
ITC Hotels
Exterminators PLC
Emkay Global
Private Client Group Research summarized from KIE research report
Kahawatte Plantations PLC
Elara Securities
10 notes from quant Mutual Fund · all time
The factsheet discloses Indegene as an unhedged holding at 3.89% of NAV.
Read this note →The factsheet discloses GlaxoSmithKline Pharmaceuticals as an unhedged holding at 3.94% of NAV.
Read this note →The factsheet discloses Piramal Finance as an unhedged holding at 3.97% of NAV.
Read this note →The factsheet discloses LG Electronics India as an unhedged holding at 4.14% of NAV.
Read this note →The factsheet discloses Zydus Lifesciences as an unhedged holding at 4.34% of NAV.
Read this note →The factsheet discloses NSE of India as an unhedged holding at 4.89% of NAV.
Read this note →The factsheet discloses Gujarat Themis Biosyn as an unhedged holding at 5.24% of NAV.
Read this note →The factsheet discloses Laurus Labs as the second-largest unhedged position of the Equity Ex-Top 100 fund at 7.11% of NAV.
Read this note →The factsheet lists Indus Towers as the largest unhedged position of the qsif Equity Ex-Top 100 Long-Short Fund at 9.21% of NAV as on 30 September 2026.
Read this note →